Phone: (212) 746-5788
Fax: (212) 746-0975
March 24, 2010 8:16 am
Poniard suspends regulatory efforts on key drug - Reuters
Google News - Prostate Cancer
Poniard suspends regulatory efforts on key drug Reuters Lazard Capital Markets analyst Joel Sendek said given the failure of the drug in the lung cancer trial and "underwhelming" data in colorectal and prostate ... |